SCHEMBL24908360

SCHEMBL24908360

Bc1c(B)c(B)c2c(-c3ccc4oc5cc6ccccc6cc5c4c3)c3c(B)c(B)c(B)c(B)c3c(-c3ccc(-c4cc5ccccc5c5ccccc45)cc3)c2c1B

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.34
MAPT P10636 4/20 0.34
ALDH1A1 P00352 4/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ESR1 P03372 1/20 0.34
POLB P06746 1/20 0.34
HPGD P15428 4/20 0.33
TSHR P16473 3/20 0.33
HSD17B10 Q99714 3/20 0.33
CASP1 P29466 2/20 0.33
ALOX15 P16050 1/20 0.33
CASP7 P55210 1/20 0.33
ALOX5 P09917 3/20 0.33
CYP11B1 P15538 1/20 0.33
GPR84 Q9NQS5 8/20 0.32
MAOB P27338 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
GLA P06280 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24908230 0.93 ALDH1A1 (0.34) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL23109427 0.88 KMT2A (0.36) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL21940511 0.88 ENPP3 (0.34) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL16068033 0.87 CYP11B1 (0.37) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL21940070 0.87 PLA2G2A (0.36) KDM4EMAPTALDH1A1ESR1POLB
SCHEMBL24908177 0.87 KDM4E (0.36) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL24908327 0.87 KDM4E (0.36) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL24908221 0.87 KDM4E (0.37) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL23109602 0.86 PLA2G2A (0.35) KDM4EMAPTALDH1A1ESR1POLB
SCHEMBL26019202 0.86 PLA2G2A (0.35) KDM4EMAPTALDH1A1ESR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS MRPS22, RER1, EMC2 KDM4E 2476/4885MAPT 3554/4885ALDH1A1 1929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.